Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  SI-BONE, Inc.    SIBN

SI-BONE, INC.

(SIBN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/17/2020 11/18/2020 11/19/2020 11/20/2020 11/23/2020 Date
23.29(c) 22.45(c) 21.63(c) 22.03(c) 21.82(c) Last
163 321 325 265 223 664 203 127 109 120 Volume
-2.39% -3.61% -3.65% +1.85% -0.95% Change
More quotes
Financials (USD)
Sales 2020 73,4 M - -
Net income 2020 -44,2 M - -
Net cash position 2020 79,3 M - -
P/E ratio 2020 -14,2x
Yield 2020 -
Sales 2021 94,8 M - -
Net income 2021 -41,3 M - -
Net cash position 2021 49,3 M - -
P/E ratio 2021 -16,2x
Yield 2021 -
Capitalization 706 M 706 M -
EV / Sales 2020 8,54x
EV / Sales 2021 6,93x
Nbr of Employees 262
Free-Float 96,5%
More Financials
Company
SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented... 
More about the company
Notations Surperformance© of SI-BONE, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about SI-BONE, INC.
11/03SI BONE : Management's Discussion and Analysis of Financial Condition and Result..
AQ
11/02SI-BONE : 3Q Earnings Snapshot
AQ
11/02SI-BONE, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
11/02SI BONE : Reports Third Quarter 2020 Financial Results and 2020 Revenue Guidance
AQ
11/02SI-BONE, Inc. Reports Third Quarter 2020 Financial Results and 2020 Revenue G..
GL
10/19SI BONE : To Report Third Quarter 2020 Financial Results on November 2, 2020
AQ
10/19SI-BONE To Report Third Quarter 2020 Financial Results on November 2, 2020
GL
10/16SI-BONE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/15SI BONE : NASS virtual Conference Surgeon Panel Presentation
PU
10/14SI BONE : Announces Pricing of Public Offering of Common Stock
AQ
10/14SI-BONE Announces Pricing of Public Offering of Common Stock
GL
10/14SI BONE : Announces Launch of Public Offering of Common Stock
AQ
10/14SI-BONE Announces Launch of Public Offering of Common Stock
GL
10/08SI-BONE, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
10/08SI BONE : Reports Preliminary Unaudited Revenue for the Third Quarter 2020 and P..
AQ
More news
News in other languages on SI-BONE, INC.
03/04SI-BONE, INC. : publication des résultats annuels
03/04SI-BONE, INC. : Veröffentlichung des Jahresergebnisses
More news
Chart SI-BONE, INC.
Duration : Period :
SI-BONE, Inc. Technical Analysis Chart | SIBN | US8257041090 | MarketScreener
Technical analysis trends SI-BONE, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 27,14 $
Last Close Price 21,82 $
Spread / Highest target 37,5%
Spread / Average Target 24,4%
Spread / Lowest Target 14,6%
EPS Revisions
Managers
NameTitle
Jeffrey W. Dunn Chairman, President & Chief Executive Officer
Laura A. Francis Chief Operating & Financial Officer
Scott A. Yerby Chief Technology Officer
W. Carlton Reckling Chief Medical Officer & VP-Medical Affairs
Gregory K. Hinckley Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SI-BONE, INC.1.49%706
NOVOCURE LIMITED57.07%13 683
MASIMO CORPORATION55.32%13 516
ASAHI INTECC CO., LTD.2.34%8 167
GETINGE AB6.55%5 784
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.42.18%4 402